{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Skye Bioscience, Inc."},"Symbol":{"label":"Symbol","value":"SKYE"},"Address":{"label":"Address","value":"11250 EL CAMINO REAL,SUITE 100, SAN DIEGO, California, 92130, United States"},"Phone":{"label":"Phone","value":"+1 858 410-0266"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. It researches and develops and plans to commercialize cannabinoid derivatives through its own directed research efforts and through several license agreements with the University of Mississippi. The company's lead compound, SBI-100, is initially being developed to treat ocular disease."},"CompanyUrl":{"label":"Company Url","value":"https://skyebioscience.com/"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Christopher G. Twitty","title":"Chief Scientific Officer"},{"name":"Puneet S. Arora","title":"Chief Medical Officer"},{"name":"Punit S. Dhillon","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}